ELECTROCARDIOGRAPHIC MONITORING OF PATIENTS RECEIVING PHASE-I CANCER-CHEMOTHERAPY

被引：0
|
作者：
HERSH, MR
LINN, W
KUHN, JG
VONHOFF, DD
机构：
[1] UNIV TEXAS,HLTH SCI CTR,DEPT MED,DIV ONCOL HEMATOL,7703 FLOYD CURL DR,SAN ANTONIO,TX 78284
[2] UNIV TEXAS,HLTH SCI CTR,DEPT PHARMACOL,SAN ANTONIO,TX 78284
[3] AUDIE L MURPHY MEM VET HOSP,SAN ANTONIO,TX 78284
来源：
CANCER TREATMENT REPORTS | 1986年 / 70卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：349 / 352
页数：4
相关论文
共 50 条
  • [41] THE ROLE OF PLASMA-LEVEL MONITORING IN CANCER-CHEMOTHERAPY
    DONEHOWER, RC
    ERLICHMAN, C
    TRENDS IN PHARMACOLOGICAL SCIENCES, 1981, 2 (03) : 64 - 66
  • [42] DECISION-ANALYSIS OF HEMATOPOIETIC GROWTH-FACTOR USE IN PATIENTS RECEIVING CANCER-CHEMOTHERAPY
    MAYORDOMO, JI
    RIVERA, F
    DIAZPUENTE, MT
    LIANES, P
    CORTESFUNES, H
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1993, 85 (15) : 1251 - 1252
  • [43] DECISION-ANALYSIS OF HEMATOPOIETIC GROWTH-FACTOR USE IN PATIENTS RECEIVING CANCER-CHEMOTHERAPY
    LYMAN, GH
    LYMAN, CG
    SANDERSON, RA
    BALDUCCI, L
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1993, 85 (06) : 488 - 493
  • [44] IMMUNOLOGICAL EVALUATION OF PEDIATRIC CANCER-PATIENTS RECEIVING RECOMBINANT INTERLEUKIN-2 IN A PHASE-I TRIAL
    TRUITT, RL
    PIASKOWSKI, V
    KIRCHNER, P
    MCOLASH, L
    CAMITTA, BM
    CASPER, JT
    JOURNAL OF IMMUNOTHERAPY, 1992, 11 (04): : 274 - 285
  • [45] PARVOVIRUS-B19 INFECTION IN PATIENTS RECEIVING CANCER-CHEMOTHERAPY - THE EXPANDING SPECTRUM OF DISEASE
    GRAEVE, JLA
    DEALARCON, PA
    NAIDES, SJ
    AMERICAN JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 1989, 11 (04): : 441 - 444
  • [46] DETERMINANTS OF ANTICIPATORY NAUSEA AND ANTICIPATORY VOMITING IN ADULTS RECEIVING CANCER-CHEMOTHERAPY
    PICKETT, M
    CANCER NURSING, 1991, 14 (06) : 334 - 343
  • [47] A PHASE-I TRIAL OF RECOMBINANT GAMMA INTERFERON IN PATIENTS WITH CANCER
    FOON, KA
    SHERWIN, SA
    ABRAMS, PG
    STEVENSON, HC
    HOLMES, P
    MALUISH, AE
    OLDHAM, RK
    HERBERMAN, RB
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 1985, 20 (03) : 193 - 197
  • [48] CLINICAL AND MICROBIOLOGICAL STUDIES OF PATIENTS ON CANCER-CHEMOTHERAPY
    EDGERTON, M
    BENGTSSON, CE
    SLOTS, J
    JOURNAL OF DENTAL RESEARCH, 1983, 62 : 295 - 295
  • [49] PHARMACOKINETICS OF TAUROMUSTINE IN CANCER-PATIENTS - PHASE-I STUDIES
    GUNNARSSON, PO
    VIBEPETERSEN, J
    MACPHERSON, JS
    WARRINGTON, PS
    POLACEK, J
    ELLMAN, M
    HANSEN, HH
    SMYTH, JF
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1989, 23 (03) : 176 - 180
  • [50] A PHASE-I ANTIEMETIC STUDY OF MDL-73,147EF, A NOVEL 5-HYDROXYTRYPTAMINE ANTAGONIST IN CANCER-PATIENTS RECEIVING EMETOGENIC CHEMOTHERAPY
    MERROUCHE, Y
    CATIMEL, G
    REBATTU, P
    DUMORTIER, A
    GUASTALLA, JP
    OGRADY, P
    CLAVEL, M
    ANNALS OF ONCOLOGY, 1994, 5 (06) : 549 - 551
12345